Short answer: The US Food and Drug Administration’s January 2026 general-wellness guidance is not a blanket clearance for a wellness capsule. A buyer still needs to identify the exact model, intended use, user risks and every claim that will appear in a sales page or service menu. The Federal Trade Commission separately expects health-related advertising claims to be truthful and adequately supported.
For a US spa or wellness operator, this matters at the procurement stage. A capsule may be sold as a place for a relaxation experience, while another seller may attach claims about diagnosing a condition or treating disease. The words and evidence are not interchangeable. Neither the enclosure’s appearance nor a supplier’s generic certificate determines how a particular claim is treated.
What changed in January 2026?
The FDA issued a new version of its General Wellness: Policy for Low Risk Devices guidance on 6 January 2026, replacing the 2019 version. It describes the agency’s approach to products intended only for general wellness use that present low risk. The document also explains that some software functions supporting a healthy lifestyle, without a disease-related purpose, fall outside the statutory definition of a device. It is guidance, not a product approval or a finding that every wellness product is safe or effective.
Translate a capsule brochure into a claim register
Before ordering, create one line for each statement you expect to make publicly. Separate observable equipment facts, such as the bed format, controls and dimensions, from experience descriptions and from claimed health outcomes. Ask the supplier which exact model and configuration support every factual statement. If a claim suggests diagnosis, disease prevention or treatment, stop and obtain specialist US regulatory advice before using it.
This is especially important for a capsule that combines heat, sound, vibration, light or assessment software. A shared product name can cover different components. Do not import a feature from a photograph, another model’s manual or a different market’s listing into the US offer.
Low risk is a separate question
The FDA guidance asks whether the product is both intended for general wellness and low risk. That is not a permission to skip electrical, heat or operational safety. For an enclosed unit, buyers should request the current operating manual, power specification, emergency-stop and exit procedure, cleaning instructions, warnings, and evidence for the model being quoted. Have the operator rehearse how a client leaves the capsule and how staff stop a session.
Advertising has its own evidence test
The FTC’s health-products guidance says advertisers need support for both express and implied objective claims. A statement can imply a health result even when it avoids the word “treat.” Images, testimonials and the surrounding page contribute to that impression. A supplier’s general assurance is not a substitute for evidence relevant to the exact claim and product.
A practical US buyer’s brief
- Record the exact model, installed options and destination state.
- List every proposed claim and mark whether it describes a feature, an experience or a health outcome.
- Request current specifications, operating instructions and model-specific safety documents.
- Ask a qualified adviser to review any disease-related or diagnostic wording before launch.
- Train staff on the actual delivered configuration, not a generic sales image.
TUOKE perspective: We describe wellness capsules by their verifiable configuration and intended commercial workflow. Product options and documentation must be confirmed for the quoted model. This article is an editorial procurement guide, not an FDA classification, legal opinion or medical advice.
Primary sources
- US FDA, General Wellness: Policy for Low Risk Devices, issued 6 January 2026; reviewed 29 September 2026.
- US FTC, Health Products Compliance Guidance; reviewed 29 September 2026.
Related TUOKE equipment: wellness capsules.